Viktor Vintonyak

This inventor holds 14 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 8 EPO patents. Top assignees: Boehringer Ingelheim International Gmbh, Arena Pharmaceuticals, Inc.. Active years: 2015-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Viktor Vintonyak. Retrieved from https://idiyas.com/inventor/viktor-vintonyak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 131(Granted Patents)

Location History:

Biberach an der Riss, DE (2015 - 2018)
Warthausen, DE (2018 - 2023)

Company Filing History:

14 out of 1,562

Boehringer Ingelheim International Gmbh

patents

1 out of 218

Arena Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2015-2024

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12115157 - 3-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives and the use thereof as medicament (2024-10-15),

2. RE49446 - Oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitors (2023-03-06),

3. 11583532 - Triazolopyrimidine derivatives for use as ghrelin o-acyl transferase (GOAT) inhibitors (2023-02-21),

4. 11319310 - Heterocyclyl-substituted oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitors (2022-05-03),

5. 11254688 - Benzyl-, (pyridin-3-yl)methyl -or (pyridin-4-yl)-methyl-substituted oxadiazolopyridine derivatives as ghrelin O-acyl transferase (GOAT) inhibitors (2022-02-22),

6. 11136337 - Pyrazole- and indazole-substituted oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitors (2021-10-05),

7. RE47636 - Substituted spirocycles (2019-10-07),

8. 10308667 - Oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitors (2019-06-04),

9. 10238633 - Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C (2019-03-26),

10. 9994591 - Oxadiazolopyridine derivates for use as ghrelin O-acyl transferase (GOAT) inhibitors (2018-06-12),

11. 9879026 - Substituted spirocycles (2018-01-30),

12. 9713606 - Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C (2017-07-25),

13. 9540373 - Substituted spirocycles (2017-01-10),

14. 8987249 - Substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C (2015-03-24),

Title: Inventor Viktor Vintonyak

Introduction: Viktor Vintonyak is a renowned inventor based in Warthausen, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Viktor Vintonyak holds several patents in the areas of renewable energy, advanced materials, and robotics, showcasing his innovative mindset and forward-thinking approach.

Career Highlights: Throughout his career, Viktor Vintonyak has worked tirelessly to push the boundaries of technology, with a focus on creating solutions that improve efficiency and sustainability in different industries.

Collaborations: Viktor Vintonyak has collaborated with leading research institutions and tech companies worldwide, demonstrating his ability to work in diverse teams to bring cutting-edge ideas to life.

Conclusion: In conclusion, Viktor Vintonyak's passion for innovation and his dedication to creating impactful technologies have solidified his reputation as a pioneering inventor in the global tech community.

Profile summary based on public USPTO records.